Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Common Equity: 2011-2012

Historic Common Equity for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Dec 2012 value amounting to $3.1 million.

  • Sonoma Pharmaceuticals' Common Equity rose 1819.02% to $3.1 million in Q4 2012 from the same period last year, while for Dec 2012 it was $3.1 million, marking a year-over-year increase of 1819.02%. This contributed to the annual value of -$868,000 for FY2012, which is 151.03% down from last year.
  • Latest data reveals that Sonoma Pharmaceuticals reported Common Equity of $3.1 million as of Q4 2012, which was up 724.35% from -$501,000 recorded in Q3 2012.
  • Sonoma Pharmaceuticals' Common Equity's 5-year high stood at $3.1 million during Q4 2012, with a 5-year trough of -$868,000 in Q1 2012.
  • Its 2-year average for Common Equity is $527,000, with a median of $252,500 in 2011.
  • Within the past 5 years, the most significant YoY rise in Sonoma Pharmaceuticals' Common Equity was 1,819.02% (2012), while the steepest drop was 268.38% (2012).
  • Quarterly analysis of 2 years shows Sonoma Pharmaceuticals' Common Equity stood at $163,000 in 2011, then spiked by 1,819.02% to $3.1 million in 2012.
  • Its Common Equity was $3.1 million in Q4 2012, compared to -$501,000 in Q3 2012 and $342,000 in Q2 2012.